Meghan Gregg, NP

Meghan Gregg practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Meghan Gregg's NPI, 1114438033, was assigned on October 18, 2017. Meghan Gregg holds Idaho license 57197.

Meghan Gregg's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Meghan Gregg's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Meghan Gregg is also affiliated with Northwest Specialty Hospital. The medical group on file is Kootenai Health. Dmand AI also links Meghan Gregg to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account. Meghan Gregg's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Meghan Gregg practices, 7 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Meghan Gregg's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Meghan Gregg is licensed in Idaho.

CMS counts 208 Medicare patients who saw Meghan Gregg in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have diabetes, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Meghan Gregg's median patient age at 69, with 53% women.

In 2024, Meghan Gregg wrote 4,414 Medicare Part D claims for 491 patients. 28% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Meghan Gregg for performance year 2024, reported through an alternative payment model (APM). Meghan Gregg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Meghan Gregg as offering telehealth.

CMS Open Payments shows 2 general payments to Meghan Gregg from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Beta Bionics, Inc. paid the most, $52.